Biclonal bacteremia due to Stenotrophomonas maltophilia in a cancer patient.
Lechner
A
A
Department of Medicine III, St.-Johanns-Spital, Landeskliniken Salzburg, Austria. A.Lechner@lks.at
Hindler
J F
JF
Nelson
S F
SF
D000293:Adolescent; D016470:Bacteremia / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D006528:Carcinoma, Hepatocellular / Q000276:immunology / Q000473:pathology / Q000601:surgery; D002442:Ceftazidime / Q000008:administration & dosage; D004359:Drug Therapy, Combination / Q000008:administration & dosage*; D005260:Female; D005500:Follow-Up Studies; D016905:Gram-Negative Bacterial Infections / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D006801:Humans; D016867:Immunocompromised Host; D008113:Liver Neoplasms / Q000276:immunology / Q000473:pathology / Q000601:surgery; D008826:Microbial Sensitivity Tests; D009362:Neoplasm Metastasis; D009894:Opportunistic Infections / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D020615:Stenotrophomonas maltophilia / Q000187:drug effects / Q000302:isolation & purification*; D016896:Treatment Outcome; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000008:administration & dosage
D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D002442:Ceftazidime